Dr. Wenge Zhong, Chief Technology Officer, co-authored 2 articles with his former colleagues at Amgen Inc.

Cryo-EM structures of PAC1 receptor reveal ligand binding mechanism, Nature's Cell Research (February 2020)

Structure-guided discovery of a single-domain antibody agonist against human apelin receptor, Science Advances (January 2020)

Dr. Daopeng Yuan, Principle Scientist, is the first author of an article in recent issue of Nature Chemical Biology

Activation of the α_2B adrenoceptor by the sedative sympatholytic dexmedetomidine, Nature Chemical Biology (March 2020)